Comparison of different strategies to select aptamers against a transmembrane protein target

Oligonucleotides

Volumn 16, Issue 4, 2006, Pages 323-335

  Pestourie, Carine ^a   Cerchia, Laura ^b   Gombert, Karine ^a   Aissouni, Youssef ^c   Boulay, Jocelyne ^c   De Franciscis, Vittorio ^b   Libri, Domenico ^c   Tavitian, Bertrand ^a   Ducongé, Frédéric ^a  

^a DIF   (France)

^b CNR   (Italy)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; MEMBRANE PROTEIN; PROTEIN RET;

ARTICLE; CELL LINE; CELL MEMBRANE; CELL STRAIN; CELL SURFACE; CELL TRANSFORMATION; COMBINATORIAL CHEMISTRY; CONFORMATION; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

AMINO ACID SUBSTITUTION; ANIMALS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CROSS-LINKING REAGENTS; HUMANS; LIGANDS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEIC ACID CONFORMATION; PC12 CELLS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-RET; RATS; RECOMBINANT PROTEINS; SELEX APTAMER TECHNIQUE;

EID: 33845999946     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.16.323     Document Type: Article

References (29)

1. BARTEL, D.P., and SZOSTAK, J.W. (1993). Isolation of new ribozymes from a large pool of random sequences [see comment]. Science 261, 1411-1418.
2. BLANK, M., WEINSCHENK, T., PRIEMER, M., and SCHLUESENER, H. (2001). Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels, selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem. 276, 16464-16468.
3. CALIFANO, D., D'ALESSIO, A., COLUCCI-D'AMATO, G.L., DE VITA, G., MONACO, C., SANTELLI, G., DI FIORE, P.P., VECCHIO, G., FUSCO, A., SANTORO, M., and DE FRANCISCIS, V. (1996). A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc. Natl. Acad. Sci. USA 93, 7933-7937.
4. CERCHIA, L., DUCONGE, F., PESTOURIE, C., BOULAY, J., AISSOUNI, Y., GOMBERT, K., TAVITIAN, B., FRANCISCIS, V.D., and LIBRI, D. (2005). Neutralizing Aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3, e123.
5. CERCHIA, L., LIBRI, D., CARLOMAGNO, M.S., and DE FRANCISCIS, V. (2003). The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret. Biochem. J. 372, 897-903.
6. CHEN, C.H., CHERNIS, G.A., HOANG, V.Q., and LANDGRAF, R. (2003). Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc. Natl. Acad. Sci. USA 100, 9226-9231.
7. CHU, T.C., TWU, K.Y., ELLINGTON, A.D., and LEVY, M. (2006). Aptamer mediated siRNA delivery. Nucleic Acids Res. 34, e73.
8. CUI, Y., RAJASETHUPATHY, P., and HESS, G.P. (2004). Selection of stable RNA molecules that can regulate the channel-opening equilibrium of the membrane-bound gamma-aminobutyric acid receptor. Biochemistry 43, 16442-16449.
9. DANIELS, D.A., CHEN, H., HICKE, B.J., SWIDEREK, K.M., and GOLD, L. (2003). A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. USA 100, 15416-15421.
10. DANIELS, D.A., SOHAL, A.K., REES, S., and GRISSHAMMER, R. (2002). Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. Anal. Biochem. 305, 214-226.
11. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
12. GSCHWIND, A., FISCHER, O.M., and ULLRICH, A. (2004). The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4, 361-370.
13. HICKE, B.J., MARION, C., CHANG, Y.F., GOULD, T., LYNOTT, C.K., PARMA, D., SCHMIDT, P.G., and WARREN, S. (2001). Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 276, 48644-48654.
14. HOMANN, M., and GORINGER, H.U. (1999). Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 27, 2006-2014.
15. KRAUSE, D.S., and VAN ETTEN, R.A. (2005). Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med. 353, 172-187.
16. LUPOLD, S.E., HICKE, B.J., LIN, Y., and COFFEY, D.S. (2002). Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62, 4029-4033.
17. MCNAMARA II, J.O., ANDRECHEK, E.R., WANG, Y., VILES, K.D., REMPEL, R.E., GILBOA, E., SULLENGER, B.A., and GIANGRANDE, P.H. (2006). Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24, 1005-1015.
18. MI, J., ZHANG, X., GIANGRANDE, P.H., MCNAMARA II, J.O., NIMJEE, S.M., SARRAF-YAZDI, S., SULLENGER, B.A., and CLARY, B.M. (2005). Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem. Biophys. Res. Commun. 338, 956-963.
19. MORI, T., OGURO, A., OHTSU, T., and NAKAMURA, Y. (2004). RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucleic Acids Res. 32, 6120-6128.
20. MORRIS, K.N., JENSEN, K.B., JULIN, C.M., WEIL, M., and GOLD, L. (1998). High affinity ligands from in vitro selection: Complex targets. Proc. Natl. Acad. Sci. USA 95, 2902-2907.
21. OHUCHI, S.P., OHTSU, T., and NAKAMURA, Y. (2006). Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. Biochimie 88, 897-904.
22. OSBORNE, S.E., MATSUMURA, I., and ELLINGTON, A.D. (1997). Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr. Opin. Chem. Biol. 1, 5-9.
23. PESTOURIE, C., TAVITIAN, B., and DUCONGE, F. (2005). Aptamers against extracellular targets for in vivo applications. Biochimie 87, 921-930.
24. THIEL, K. (2004). Oligo oligarchy-the surprisingly small world of aptamers. Nat. Biotechnol. 22, 649-651.
25. THOMPSON, J.D., GIBSON, T.J., PLEWNIAK, F., JEAN-MOUGIN, F., and HIGGINS, D.G. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25, 4876-4882.
26. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
27. VLASSOV, A., KHVOROVA, A., and YARUS, M. (2001). Binding and disruption of phospholipid bilayers by supramolecular RNA complexes, Proc. Natl. Acad. Sci. USA 98, 7706-7711.
28. WANG, J., JIANG, H., and LIU, F. (2000). In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. RNA 6, 571-583.
29. ZUKER, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.